Characterization of SLC26A9 in patients with CF-like lung disease

Human Mutation

Volumn 34, Issue 10, 2013, Pages 1404-1414

  Bakouh, Naziha ^a,b   Bienvenu, Thierry ^b,c   Thomas, Annick ^d   Ehrenfeld, Jordi ^e   Liote, Huguette ^f   Roussel, Delphine ^a   Duquesnoy, Philippe ^g   Farman, Nicolette ^h   Viel, Marion ^b,c   Cherif Zahar, Baya ^a,b   Amselem, Serge ^g   Taam, Rola Abou ⁱ   Edelman, Aleksander ^a,b   Planelles, Gabrielle ^a,b   Sermet Gaudelus, Isabelle ^a,b,i  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔTEL DIEU   (France)

^d UNIVERSITÉ PAUL SABATIER   (France)

^e CNRS   (France)

^f HÔPITAL TENON   (France)

^g ARMAND TROUSSEAU HOSPITAL   (France)

^h CENTRE DE RECHERCHE DES CORDELIERS   (France)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Bronchiectasis; Cystic fibrosis; SLC26A9; Xenopus laevis oocytes

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; COMPLEMENTARY DNA; SOLUTE CARRIER 26A9 PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BRONCHIECTASIS; CHILD; CHLORIDE CONDUCTANCE; CHRONIC COUGH; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUCOCILIARY CLEARANCE; OOCYTE; PATHOGENICITY; PKA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT MUCOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SPUTUM; STRUCTURE ACTIVITY RELATION; TRANSLATION INITIATION; XENOPUS LAEVIS;

XENOPUS LAEVIS;

BRONCHIECTASIS; CYSTIC FIBROSIS; SLC26A9; XENOPUS LAEVIS OOCYTES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIPORTERS; CASE-CONTROL STUDIES; CHILD; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EXONS; FEMALE; GENE EXPRESSION; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; MUTATION; OOCYTES; PEPTIDE FRAGMENTS; PHENOTYPE; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; TOMOGRAPHY, X-RAY COMPUTED; XENOPUS LAEVIS; YOUNG ADULT;

EID: 84884530496     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22382     Document Type: Article

References (47)

1. Anagnostopoulou P, Riederer B, Duerr J, Michel S, Binia A, Agrawal A, Liu X, Kalitzki K, Xiao F, Chen M, Schatterny J, Hartmann D, et al. 2012. J SLC26A9-mediated chloride secretion prevents mucus obstruction in airway inflammation. J Clin Invest 122:3629-3634.
2. Avella M, Borgese F, Ehrenfeld J. 2011a. Characterization of the L683P mutation of SLC26A9 in Xenopus oocytes. Biochem Biophys Acta 1810:277-283.
3. Avella M, Loriol C, Boulukos K, Borgese F, Ehrenfeld J. 2011b. SLC26A9 stimulates CFTR expression and function in human bronchial cell lines. J Cell Physiol 226(1):212-223.
4. Babu M, Greenblatt JF, Emili A, Strynadka NC, Reithmeier RA, Moraes TF. 2010. Structure of a SLC26 anion transporter STAS domain in complex with acyl carrier protein: implications for E. coli YchM in fatty acid metabolism. Structure 18(11):1450-1462.
5. Bakouh N, Benjelloun F, Hulin P, Brouillard F, Edelman A, Cherif-Zahar B, Planelles G. 2004. NH3 is involved in the NH4 +transport induced by the functional expression of the human Rh C glycoprotein. J Biol Chem 279(16):15975-15983.
6. Bakouh N, Chérif-Zahar B, Hulin P, Prié D, Friedlander G, Edelman A, Planelles G. 2012. Functional interaction between CFTR and the sodium-phosphate co-transport type 2a in Xenopus laevis oocytes. PLoS ONE 7(4):e34879.
7. Bertrand C, Zhang R, Pilewski J, Frizzell R. 2009. SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia. J Gen Physiol 133(4):421-438.
8. th Annual North American Cystic Fibrosis Conference, Orlando, October 11-13, 2012. Ped Pulmonol 47(S35):184-185.
9. Bienvenu T, Sermet-Gaudelus I, Burgel PR, Hubert D, Crestani B, Bassinet L, Dusser D, Fajac I. 2010. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 181(10):1078-1084.
10. Bombieri C, Claustres M, De Boeck K, Derichs N, Dodge J, Girodon E, Sermet I, Schwarz M, Tzetis M, Wilschanski M, Bareil C, Bilton D, et al. 2011. Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros 10(Suppl 2):S86-S102.
11. Boucher R. 2010. Bronchiectasis. A continuum of ion transport dysfunction or multiple hits? Am J Resp Crit Care (181):1017-1019.
12. Castellani C, Quinzii C, Altieri S, Mastella G, Assael BM. 2001. A pilot survey of cystic fibrosis clinical manifestations in CFTR mutation heterozygotes. Genet Test 5(3):249-254.
13. + transporter. J Membr Biol 128(3):125-140.
14. Chang M-H, Plata C, Sindić A, Ranatunga WK, Chen AP, Zandi-Nejad K, Chan KW, Thompson J, Mount DB, Romero MF. 2009b. Slc26a9 is inhibited by the R-region of CFTR via the STAS domain. J Biol Chem 284(28306-18):28306-28318.
15. Chen AP, Chang MH, Romero MF. 2012. Functional analysis of nonsynonymous single nucleotide polymorphisms in human SLC26A9. Hum Mutat 33(8):1275-1284.
16. Demitrack ES, Soleimani M, Montrose MH. 2010. Damage to the gastric epithelium activates cellular bicarbonate secretion via SLC26A9 Cl(-)/HCO(3)(-). Am J Physiol Gastrointest Liver Physiol 299(1):G255-G264.
17. Dorwart MR, Shcheynikov N, Wang Y, Stippec S, Muallem S. 2007. SLC26A9 is a Cl(-) channel regulated by the WNK kinases. J Physiol 584(Pt 1):333-345.
18. Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F, Hazani E, Nassir E, Baxevanis ADs. 1997. Pendred syndrome is caused by mutations in a putative sulphate transporter gene(PDS). Nat Genet 17(4):411-422.
19. Fajac I, Viel M, Gaitch N, Hubert D, Bienvenu T. 2009. Combination of ENaC and CFTR mutations may predispose to cystic fibrosis-like disease. Eur Respir J 34(3):772-773.
20. Gallet X, Charloteaux B, Thomas A, Brasseur R. 2000. A fast method to predict protein interaction sites from sequences. J Mol Biol 302(4):917-926.
21. Girodon E, Cazeneuve C, Lebargy F, Chinet T, Costes B, Ghanem N, Martin J, Lemay S, Scheid P, Housset B, Bignon J, Goossens M. 1997. CFTR gene mutations in adults with disseminated bronchiectasis. Eur J Hum Genet 5(3):149-155.
22. Gonska T, Choi P, Stephenson A, Ellis L, Martin S, Solomon M, Dupuis A, Dorfman R, Zielenski J, Ooi CY, Weiser W, Durie PR, Tullis E. 2012. Role of cystic fibrosis transmembrane conductance regulator in patients with chronic sinopulmonary disease. Chest 142(4):996-1004.
23. Groman JD, Meyer ME, Wilmott RW, Zeitlin PL, Cutting GR. 2002. Variant cystic fibrosis phenotypes in the absence of CFTR mutations. N Engl J Med 347(6):401-407.
24. Hastbacka J, Superti-Furga A, Wilcox WR, Rimoin DL, Cohn DH, Lander ES. 1996. Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfatetransporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias. Am J Hum Genet 58(2):255-262.
25. Homma K, Miller KK, Anderson CT, Sengupta S, Du GG, Aguiñaga S, Cheatham M, Dallos P, Zheng J. 2010. Interaction between CFTR and prestin (SLC26A5). Biochem Biophys Acta 1798(6):1029-1040.
26. Kelly M, Trudel S, Brouillard F, Bouillaud F, Colas J, Nguyen-Khoa T, Ollero M, Edelman A, Fritsch J. 2010. Cystic fibrosis transmembrane regulator inhibitors CFTR(inh)-172 and GlyH-101 target mitochondrial functions, independently of chloride channel inhibition. J Pharmacol Exp Ther 333(1):60-69.
27. Ko SB, Shcheynikov N, Choi JY, Luo X, Ishibashi K, Thomas PJ, Kim JY, Kim KH, Lee MG, Naruse S, Muallem S. 2002. A molecular mechanism for aberrant CFTR-dependent HCO(3)(-) transport in cystic fibrosis. EMBO J 21: 5662-5672.
28. Ko SB, Zeng W, Dorwart MR, Luo X, Kim KH, Millen L, Goto H, Naruse S, Soyombo A, Thomas PJ, Muallem S. 2004. Gating of CFTR by the STAS domain of SLC26 transporters. Nat Cell Biol 6:343-350.
29. Lewarchik CM, Peters KW, Qi J, Frizzell RA. 2008. Regulation of CFTR trafficking by its R domain. J Biol Chem 283(42):28401-28412.
30. Lohi H, Kujala M, Makela S, Lehtonen E, Kestila M, Saarialho-Kere U, Markovich D, Kere J. 2002. Functional characterization of three novel tissue-specific anion exchangers SLC26A7, -A8, and -A9. J Biol Chem 277:14246-14254.
31. Loriol C, Dulong S, Avella M, Gabillat N, Boulukos K, Borgese F, Ehrenfeld J. 2008. Characterization of SLC26A9, facilitation of Cl(-) transport by bicarbonate. Cell Physiol Biochem 22:15-30.
32. Makela S, Kere J, Holmberg C, Hoglund P. 2002. SLC26A3 mutations in congenital chloride diarrhea. Hum Mutat 20(6):425-438.
33. Nagel G, Szellas T, Riordan JR, Friedrich T, Hartung K. 2001. Non-specific activation of the epithelial sodium channel by the CFTR chloride channel. EMBO Rep 2:249-254.
34. Pasteur M, Helliwell S, Houghton S, Webb S, Foweraker J, Coulden R, Flower C, Bilton D, Keogan, M. 2000. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 162:1277-1284.
35. Pasqualetto E, Seydel A, Pellini A, Battistutta R. 2008. Expression, purification and characterisation of the C-terminal STAS domain of the SLC26 anion transporter prestin. Protein Expr Purif 58(2):249-256.
36. Pasqualetto E, Aiello R, Gesiot L, Bonetto G, Bellanda M, Battistutta R. 2010. Structure of the cytosolic portion of the motor protein prestin and functional role of the STAS domain in SLC26/SulP anion transporters. J Mol Biol 400(3):448-462.
37. Rakonczay Z, Hegyi P, Hasegawa M, Inoue M, You J, Lida A, Ignath I, Alton EW, Griesenbach U, Ovari G, Vag J, Da Paula AC, et al. 2008. CFTR gene transfer to human cystic fibrosis pancreatic duct cells using a Sendai virus vector. J Cell Physiol 214(2):442-455.
38. Ratjen F, Döring G. 2003.Cystic fibrosis. Lancet 361(9358):681-689.
39. Rode B, Dirami T, Bakouh N, Rizk-Rabin M, Norez C, Lhuillier P, Lorès P, Jollivet M, Melin P, Zvetkova I, Bienvenu T, Becq F, et al. 2012. The testis anion transporter TAT1 (SLC26A8) physically and functionally interacts with the cystic fibrosis transmembrane conductance regulator channel: a potential role during sperm capacitation. Hum Mol Genet 21(6):1287-1298.
40. Romero MF, Chang MH, Plata C, Zandi-Nejad K, Mercado A, Broumand V, Sussman CR, Mount DB. 2006. Physiology of electrogenic SLC26 paralogues. Novartis Found Symp 273:126-138.
41. Sermet-Gaudelus I, Girodon E, Sands D, Stremmler N, Vaverova V, Deneuville E, Reix P, Bui S, Huet F, Lebourgeois M, Munck A, Iron A, et al. 2010. Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport. Am J Respir Crit Care Med 182(7):929-936.
42. Sermet-Gaudelus I, Edelman A, Fajac I. 2011. Channelopathies in bronchiectasis. Eur Respir Monograph 52:150-162.
43. Shcheynikov N, Kim KH, Kim KM, Dorwart MR, Ko SB, Goto H, Naruse S, Thomas PJ, Muallem S. 2004. Dynamic control of cystic fibrosis transmembrane conductance regulator Cl(-)/HCO3(-) selectivity by external Cl(-). J Biol Chem 279(21):21857-21865.
44. Shelden M, Howitt S, Price G. 2010. Membrane topology of the cyanobacterial bicarbonate transporter, BicA, a member of the SulP (SLC26A) family. Mol Membr Biol 27(1):12-23.
45. Sun L, Rommens JM, Corvol H, Li W, Li X, Chiang TA, Lin F, Dorfman R, Busson PF, Parekh RV, Zelenika D, Blackman SM, et al. 2012. Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis. Nat Genet 44(5):562-569.
46. Wang X, Frizzell RA, Bertrand CA. 2012. Coexpression of CFTR and SLC26A9 increases single channel conductance of CFTR. Abstract 60. The 26th Annual North American Cystic Fibrosis Conference, Orlando, October 11-13, 2012. Ped Pulmonol 47(S35):243.
47. Xu J, Song P, Miller ML, Borgese F, Barone S, Riederer B, Wang Z, Alper SL, Forte JG, Shull GE, et al. 2008. Deletion of the chloride transporter Slc26a9 causes loss of tubulovesicles in parietal cells and impairs acid secretion in the stomach. Proc Natl Acad Sci USA 105(46):17955-17960.